Placebo Group RB0026:Single intramuscular injection of 2 ml (0 mg RB0026)
Sponsors
The First Affiliated Hospital of Guangzhou Medical University
Conditions
RSV (Respiratory Syncytial Virus)Respiratory Syncytial Virus Infection
Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase IIIb Clinical Trial Evaluating the Efficacy and Safety of RB0026 Injection in Chinese Children Aged 1-2 Years
Active, not recruitingChiCTR2600116441
Start: 2026-01-09Updated: 2026-01-12
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Trial Evaluating the Efficacy and Safety of RB0026 Injection in Preterm and Term Infants in China
Active, not recruitingChiCTR2600123076
Start: 2024-10-17Updated: 2026-04-27